Parkway Cardiology Associates | Parkway Cardiology Associates

Research site
80 Vermont Avenue, Oak Ridge, Tennessee, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


2 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...

Myocardial Infarction
Drug: Evolocumab
Drug: Routine Lipid Management

Trial conditions

Infarction (3 trials)
Myocardial Infarction (3 trials)
Cardiovascular Diseases (1 trial)
Carotid Artery Diseases (1 trial)
Coronary Artery Disease (1 trial)
Coronary Disease (1 trial)
Drug-Related Side Effect... (1 trial)
Heart Diseases (1 trial)
Heart Failure (1 trial)
Myocardial Ischemia (1 trial)

And 1 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems